T. Rowe Price Associates’s Cardiff Oncology CRDF Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $95K | Buy |
30,143
+4,984
| +20% | +$15.7K | ﹤0.01% | 2902 |
|
|
2025
Q1 | $79K | Buy |
25,159
+9,769
| +63% | +$30.7K | ﹤0.01% | 2867 |
|
|
2024
Q4 | $67K | Sell |
15,390
-33,847
| -69% | -$147K | ﹤0.01% | 2887 |
|
|
2024
Q3 | $132K | Hold |
49,237
| – | – | ﹤0.01% | 2766 |
|
|
2024
Q2 | $110K | Buy |
49,237
+12,737
| +35% | +$28.5K | ﹤0.01% | 2742 |
|
|
2024
Q1 | $195K | Hold |
36,500
| – | – | ﹤0.01% | 2634 |
|
|
2023
Q4 | $55K | Hold |
36,500
| – | – | ﹤0.01% | 2794 |
|
|
2023
Q3 | $51K | Hold |
36,500
| – | – | ﹤0.01% | 2771 |
|
|
2023
Q2 | $54K | Hold |
36,500
| – | – | ﹤0.01% | 2786 |
|
|
2023
Q1 | $61K | Hold |
36,500
| – | – | ﹤0.01% | 2759 |
|
|
2022
Q4 | $51K | Hold |
36,500
| – | – | ﹤0.01% | 2808 |
|
|
2022
Q3 | $57K | Hold |
36,500
| – | – | ﹤0.01% | 2812 |
|
|
2022
Q2 | $80K | Buy |
36,500
+15,020
| +70% | +$32.9K | ﹤0.01% | 2796 |
|
|
2022
Q1 | $53K | Buy |
21,480
+800
| +4% | +$1.97K | ﹤0.01% | 2910 |
|
|
2021
Q4 | $124K | Buy |
+20,680
| New | +$124K | ﹤0.01% | 2841 |
|
|
2021
Q1 | – | Sell |
-529,627
| Closed | -$9.53M | – | 2842 |
|
|
2020
Q4 | $9.53M | Sell |
529,627
-23,732
| -4% | -$427K | ﹤0.01% | 1353 |
|
|
2020
Q3 | $7.85M | Buy |
+553,359
| New | +$7.85M | ﹤0.01% | 1347 |
|
|
2017
Q2 | – | Sell |
-17,677
| Closed | -$20K | – | 2560 |
|
|
2017
Q1 | $20K | Hold |
17,677
| – | – | ﹤0.01% | 2563 |
|
|
2016
Q4 | $37K | Sell |
17,677
-123
| -0.7% | -$257 | ﹤0.01% | 2535 |
|
|
2016
Q3 | $80K | Hold |
17,800
| – | – | ﹤0.01% | 2467 |
|
|
2016
Q2 | $81K | Buy |
+17,800
| New | +$81K | ﹤0.01% | 2448 |
|